{"title":"Longitudinal neurocognitive outcomes and predictors after unilateral combined cerebral revascularization in adult moyamoya vasculopathy.","authors":"Ruiyuan Weng, Jiabin Su, Hanqiang Jiang, Heng Yang, Xinjie Gao, Yanjiang Li, Zhiwen Jiang, Yuchao Fei, Zeran Yu, Chao Gao, Wei Ni, Yuxiang Gu","doi":"10.3171/2025.4.JNS243119","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>While most studies on adult moyamoya vasculopathy (MMV) have focused on the stroke incidence after bypass surgery, neurocognitive outcomes and predictors have rarely been investigated. The aim of this study was to evaluate the neurocognitive outcomes of adult patients with MMV after combined revascularization surgery and identify factors contributing to unfavorable outcomes.</p><p><strong>Methods: </strong>Adult patients with MMV who underwent combined revascularization surgery from March 2019 to July 2024 at a single center were prospectively observed. Neuropsychological assessments and DSA were performed approximately 6 months after surgery. Neurocognitive changes were assessed using a distribution-based approach to calculate the minimal clinically important difference.</p><p><strong>Results: </strong>A total of 204 patients (mean age 43.8 years) were included in the analysis, with a mean ± SD follow-up duration of 183.0 ± 18.2 days. Postoperatively, 166 patients (81.4%) demonstrated favorable neurocognitive outcomes, with 94 patients (46.1%) showing significant improvement and 72 patients (35.3%) remaining stable. Conversely, 38 patients (18.6%) experienced significant neurocognitive deterioration. The prevalence of vascular cognitive impairment (VCI) (p < 0.001) and the modified Rankin Scale scores (p = 0.002) significantly decreased following bypass. Multivariate analysis identified postoperative stroke complications (OR 3.57 [95% CI 1.47-8.68], p = 0.005) and posterior cerebral artery involvement (OR 2.23 [95% CI 1.01-4.93], p = 0.047) as independent risk factors for neurocognitive deterioration. Diabetes mellitus (OR 3.86 [95% CI 1.62-9.19], p = 0.002) and left-sided surgery (OR 2.01 [95% CI 1.09-3.70], p = 0.025) were independent risk factors against neurocognitive improvement, while the hemorrhagic type of MMV (OR 0.36 [95% CI 0.17-0.72], p = 0.004) was an independent protective factor.</p><p><strong>Conclusions: </strong>Combined revascularization surgery appears to be an effective treatment for improving neurocognition in patients with MMV and VCI. Insufficient preexisting collateral reserve and postoperative stroke complications might contribute to neurocognitive deterioration, while diabetes mellitus and left-sided surgery hindered neurocognitive improvement.</p>","PeriodicalId":16505,"journal":{"name":"Journal of neurosurgery","volume":" ","pages":"1-10"},"PeriodicalIF":3.6000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neurosurgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3171/2025.4.JNS243119","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: While most studies on adult moyamoya vasculopathy (MMV) have focused on the stroke incidence after bypass surgery, neurocognitive outcomes and predictors have rarely been investigated. The aim of this study was to evaluate the neurocognitive outcomes of adult patients with MMV after combined revascularization surgery and identify factors contributing to unfavorable outcomes.
Methods: Adult patients with MMV who underwent combined revascularization surgery from March 2019 to July 2024 at a single center were prospectively observed. Neuropsychological assessments and DSA were performed approximately 6 months after surgery. Neurocognitive changes were assessed using a distribution-based approach to calculate the minimal clinically important difference.
Results: A total of 204 patients (mean age 43.8 years) were included in the analysis, with a mean ± SD follow-up duration of 183.0 ± 18.2 days. Postoperatively, 166 patients (81.4%) demonstrated favorable neurocognitive outcomes, with 94 patients (46.1%) showing significant improvement and 72 patients (35.3%) remaining stable. Conversely, 38 patients (18.6%) experienced significant neurocognitive deterioration. The prevalence of vascular cognitive impairment (VCI) (p < 0.001) and the modified Rankin Scale scores (p = 0.002) significantly decreased following bypass. Multivariate analysis identified postoperative stroke complications (OR 3.57 [95% CI 1.47-8.68], p = 0.005) and posterior cerebral artery involvement (OR 2.23 [95% CI 1.01-4.93], p = 0.047) as independent risk factors for neurocognitive deterioration. Diabetes mellitus (OR 3.86 [95% CI 1.62-9.19], p = 0.002) and left-sided surgery (OR 2.01 [95% CI 1.09-3.70], p = 0.025) were independent risk factors against neurocognitive improvement, while the hemorrhagic type of MMV (OR 0.36 [95% CI 0.17-0.72], p = 0.004) was an independent protective factor.
Conclusions: Combined revascularization surgery appears to be an effective treatment for improving neurocognition in patients with MMV and VCI. Insufficient preexisting collateral reserve and postoperative stroke complications might contribute to neurocognitive deterioration, while diabetes mellitus and left-sided surgery hindered neurocognitive improvement.
目的:虽然大多数关于成人烟雾病(MMV)的研究都集中在搭桥手术后卒中的发生率上,但很少对神经认知结果和预测因素进行研究。本研究的目的是评估成人MMV患者在联合血运重建术后的神经认知结果,并确定导致不良结果的因素。方法:前瞻性观察2019年3月至2024年7月在单中心接受联合血运重建术的成年MMV患者。术后约6个月进行神经心理评估和DSA。使用基于分布的方法评估神经认知变化,以计算最小临床重要差异。结果:共纳入204例患者,平均年龄43.8岁,平均±SD随访时间183.0±18.2天。术后,166例患者(81.4%)表现出良好的神经认知预后,94例患者(46.1%)表现出显著改善,72例患者(35.3%)保持稳定。相反,38名患者(18.6%)出现了明显的神经认知恶化。血管认知功能障碍(VCI)患病率(p < 0.001)和改良Rankin量表评分(p = 0.002)在搭桥后显著降低。多因素分析发现,术后卒中并发症(OR 3.57 [95% CI 1.47-8.68], p = 0.005)和大脑后动脉受累(OR 2.23 [95% CI 1.01-4.93], p = 0.047)是神经认知功能恶化的独立危险因素。糖尿病(OR 3.86 [95% CI 1.62-9.19], p = 0.002)和左侧手术(OR 2.01 [95% CI 1.09-3.70], p = 0.025)是影响神经认知改善的独立危险因素,而MMV出血性类型(OR 0.36 [95% CI 0.17-0.72], p = 0.004)是独立保护因素。结论:联合血管重建术似乎是改善MMV和VCI患者神经认知的有效治疗方法。先前存在的侧支储备不足和术后卒中并发症可能导致神经认知功能恶化,而糖尿病和左侧手术阻碍了神经认知功能的改善。
期刊介绍:
The Journal of Neurosurgery, Journal of Neurosurgery: Spine, Journal of Neurosurgery: Pediatrics, and Neurosurgical Focus are devoted to the publication of original works relating primarily to neurosurgery, including studies in clinical neurophysiology, organic neurology, ophthalmology, radiology, pathology, and molecular biology. The Editors and Editorial Boards encourage submission of clinical and laboratory studies. Other manuscripts accepted for review include technical notes on instruments or equipment that are innovative or useful to clinicians and researchers in the field of neuroscience; papers describing unusual cases; manuscripts on historical persons or events related to neurosurgery; and in Neurosurgical Focus, occasional reviews. Letters to the Editor commenting on articles recently published in the Journal of Neurosurgery, Journal of Neurosurgery: Spine, and Journal of Neurosurgery: Pediatrics are welcome.